Business · Markets · 2 hrs ago

Swiss stocks set for firmer opening as earnings season approaches

Swiss stocks set for firmer opening as earnings season approaches

Swiss stocks were expected to open higher on Monday, with pre-market trading putting the main SMI index up 0.38% at 13,840 points.

The forecast followed a 1.1% rise in the SMI on Friday.

The briefing linked the expected gain partly to a slight easing in bond markets.

Monday was expected to bring few major news items, but companies are due to start reporting third-quarter results during the week.

Roche said it would present annual Phase III data for its eye medicine Vamikibart.

The US Food and Drug Administration has accepted an application to approve the drug and is expected to decide by July 2027.

Investors will be watching the upcoming company results and the regulatory decision for updates on the Swiss market and Roche’s drug.

Sources

Related news